Souders Financial Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$593K Sell
2,024
-56
-3% -$18.4K 0.07% 130
2025
Q4
$729K Sell
2,080
-115
-5% -$38.9K 0.08% 110
2025
Q3
$709K Sell
2,195
-339
-13% -$105K 0.08% 109
2025
Q2
$985K Sell
2,534
-604
-19% -$243K 0.13% 86
2025
Q1
$1.36M Buy
3,138
+194
+7% +$77.9K 0.19% 74
2024
Q4
$1.09M Sell
2,944
-349
-11% -$146K 0.15% 99
2024
Q3
$1.71M Sell
3,293
-1
-0% -$534 0.24% 74
2024
Q2
$1.79M Buy
3,294
+975
+42% +$515K 0.27% 69
2024
Q1
$1.2M Sell
2,319
-45
-2% -$22.4K 0.19% 83
2023
Q4
$1.11M Buy
2,364
+4
+0.2% +$1.85K 0.19% 83
2023
Q3
$1.03M Sell
2,360
-78
-3% -$35.4K 0.2% 84
2023
Q2
$1.08M Buy
2,438
+29
+1% +$13.4K 0.21% 81
2023
Q1
$1.11M Buy
2,409
+18
+0.8% +$8.57K 0.24% 80
2022
Q4
$1.23M Buy
2,391
+15
+0.6% +$7.62K 0.28% 76
2022
Q3
$1.08M Buy
2,376
+122
+5% +$58.4K 0.29% 76
2022
Q2
$1.09M Buy
2,254
+3
+0.1% +$1.48K 0.31% 69
2022
Q1
$1.11M Buy
2,251
+24
+1% +$11K 0.32% 67
2021
Q4
$1.03M Buy
2,227
+1
+0% +$421 0.3% 73
2021
Q3
$830K Sell
2,226
-519
-19% -$197K 0.27% 76
2021
Q2
$1.05M Sell
2,745
-32
-1% -$12.2K 0.35% 64
2021
Q1
$997K Buy
2,777
+26
+0.9% +$8.36K 0.39% 57
2020
Q4
$883K Buy
2,751
+3
+0.1% +$921 0.38% 56
2020
Q3
$903K Sell
2,748
-1,070
-28% -$288K 0.43% 52
2020
Q2
$1M Hold
3,818
0.57% 49
2020
Q1
$867K Buy
+3,818
New +$1.04M 0.77% 35

Other funds holding ELV

Souders Financial Advisors's ELV Position: Q1 2026 in Review

Souders Financial Advisors reduced its Elevance Health (ELV) stake by 2.7% in Q1 2026, selling an estimated $18.4K and leaving 2,024 shares worth $593K. The position accounts for 0.07% of the portfolio, ranked #130.

Souders Financial Advisors first reported a position in ELV in Q1 2020 and has held it in 25 quarters since. The position peaked at $1.79M in Q2 2024. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Souders Financial Advisors held 2,024 shares of Elevance Health worth $593K as of Q1 2026.
  • Souders Financial Advisors sold 56 Elevance Health shares in Q1 2026, an estimated $18.4K.
  • Elevance Health made up 0.07% of Souders Financial Advisors's portfolio in Q1 2026, its #130 holding.
  • Souders Financial Advisors first reported a position in Elevance Health in Q1 2020 and has held it in 25 quarters since.
  • Souders Financial Advisors's Elevance Health position peaked at $1.79M in Q2 2024.
  • 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Souders Financial Advisors's 13F filing for Q1 2026, filed 4 May 2026.